LIVZON PHARMAC (Germany) Performance

LP6 Stock  EUR 3.02  0.02  0.66%   
The company secures a Beta (Market Risk) of 0.18, which conveys not very significant fluctuations relative to the market. As returns on the market increase, LIVZON PHARMAC's returns are expected to increase less than the market. However, during the bear market, the loss of holding LIVZON PHARMAC is expected to be smaller as well. At this point, LIVZON PHARMAC GRP has a negative expected return of -0.0958%. Please make sure to verify LIVZON PHARMAC's potential upside, kurtosis, day median price, as well as the relationship between the skewness and rate of daily change , to decide if LIVZON PHARMAC GRP performance from the past will be repeated at future time.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days LIVZON PHARMAC GRP has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, LIVZON PHARMAC is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Forward Dividend Yield
0.0432
Payout Ratio
0.4583
Last Split Factor
13:10
Forward Dividend Rate
0.13
Ex Dividend Date
2025-06-13
1
Livzon Pharmaceutical Group Announces Board and Committee Positions - TipRanks
12/10/2025
2
Why Livzon Pharmaceutical Group Inc. stock attracts HNW investors - 2025 Trade Ideas Smart Money Movement Tracker - ulpravda.ru
01/08/2026
3
Goldman Sachs Downgrades LIVZON PHARMACEUTICAL GROUP INC to Sell Rating, Cuts Target Price to 2.94 -
02/06/2026
  

LIVZON PHARMAC Relative Risk vs. Return Landscape

If you would invest  330.00  in LIVZON PHARMAC GRP on December 2, 2025 and sell it today you would lose (28.00) from holding LIVZON PHARMAC GRP or give up 8.48% of portfolio value over 90 days. LIVZON PHARMAC GRP is currently producing negative expected returns and takes up 3.2506% volatility of returns over 90 trading days. Put another way, 29% of traded stocks are less volatile than LIVZON, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon LIVZON PHARMAC is expected to under-perform the market. In addition to that, the company is 4.29 times more volatile than its market benchmark. It trades about -0.03 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of volatility.

LIVZON PHARMAC Target Price Odds to finish over Current Price

The tendency of LIVZON Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 3.02 90 days 3.02 
about 87.83
Based on a normal probability distribution, the odds of LIVZON PHARMAC to move above the current price in 90 days from now is about 87.83 (This LIVZON PHARMAC GRP probability density function shows the probability of LIVZON Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon LIVZON PHARMAC has a beta of 0.18. This indicates as returns on the market go up, LIVZON PHARMAC average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding LIVZON PHARMAC GRP will be expected to be much smaller as well. Additionally LIVZON PHARMAC GRP has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   LIVZON PHARMAC Price Density   
       Price  

Predictive Modules for LIVZON PHARMAC

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as LIVZON PHARMAC GRP. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.153.026.27
Details
Intrinsic
Valuation
LowRealHigh
0.132.615.86
Details
Naive
Forecast
LowNextHigh
0.063.126.37
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.023.023.02
Details

LIVZON PHARMAC Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. LIVZON PHARMAC is not an exception. The market had few large corrections towards the LIVZON PHARMAC's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold LIVZON PHARMAC GRP, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of LIVZON PHARMAC within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.11
β
Beta against Dow Jones0.18
σ
Overall volatility
0.12
Ir
Information ratio -0.05

LIVZON PHARMAC Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of LIVZON PHARMAC for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for LIVZON PHARMAC GRP can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
LIVZON PHARMAC GRP generated a negative expected return over the last 90 days
LIVZON PHARMAC GRP has high historical volatility and very poor performance
About 54.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Goldman Sachs Downgrades LIVZON PHARMACEUTICAL GROUP INC to Sell Rating, Cuts Target Price to 2.94 -

LIVZON PHARMAC Fundamentals Growth

LIVZON Stock prices reflect investors' perceptions of the future prospects and financial health of LIVZON PHARMAC, and LIVZON PHARMAC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LIVZON Stock performance.

About LIVZON PHARMAC Performance

By analyzing LIVZON PHARMAC's fundamental ratios, stakeholders can gain valuable insights into LIVZON PHARMAC's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if LIVZON PHARMAC has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if LIVZON PHARMAC has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Livzon Pharmaceutical Group Inc. engages in the research, development, production, and distribution of pharmaceutical products in the Peoples Republic of China. Livzon Pharmaceutical Group Inc. was founded in 1985 and is based in Zhuhai, China. Livzon Pharmaceutical operates under Drug Manufacturers - Specialty Generic classification in Germany and traded on Frankfurt Stock Exchange. It employs 6963 people.

Things to note about LIVZON PHARMAC GRP performance evaluation

Checking the ongoing alerts about LIVZON PHARMAC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LIVZON PHARMAC GRP help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
LIVZON PHARMAC GRP generated a negative expected return over the last 90 days
LIVZON PHARMAC GRP has high historical volatility and very poor performance
About 54.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Goldman Sachs Downgrades LIVZON PHARMACEUTICAL GROUP INC to Sell Rating, Cuts Target Price to 2.94 -
Evaluating LIVZON PHARMAC's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate LIVZON PHARMAC's stock performance include:
  • Analyzing LIVZON PHARMAC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LIVZON PHARMAC's stock is overvalued or undervalued compared to its peers.
  • Examining LIVZON PHARMAC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating LIVZON PHARMAC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of LIVZON PHARMAC's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of LIVZON PHARMAC's stock. These opinions can provide insight into LIVZON PHARMAC's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating LIVZON PHARMAC's stock performance is not an exact science, and many factors can impact LIVZON PHARMAC's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for LIVZON Stock analysis

When running LIVZON PHARMAC's price analysis, check to measure LIVZON PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LIVZON PHARMAC is operating at the current time. Most of LIVZON PHARMAC's value examination focuses on studying past and present price action to predict the probability of LIVZON PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LIVZON PHARMAC's price. Additionally, you may evaluate how the addition of LIVZON PHARMAC to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Global Correlations
Find global opportunities by holding instruments from different markets